The Latest Cardiac and Vascular News
Global clinical program expands to the United States and Brazil following successful First-in-Human experience, marking a major milestone in development of the CARLEN™ System ATLANTA, July 7, 2026 /PRNewswire/ — Nyra Medical, Inc., a clinical-stage medical technology company developing a novel transcatheter solution for functional mitral regurgitation (FMR), today announced enrollment of […]
ATLANTA, June 18, 2026 /PRNewswire/ — Nyra Medical, a leading innovator in structural heart therapies, today announced that it has been selected as the recipient of the 2026 Jon DeHaan Foundation Award for Cardiovascular Innovation, presented during EuroPCR 2026, the world’s leading…
ATLANTA, Oct. 22, 2025 /PRNewswire/ — Nyra Medical, a leading innovator in structural heart therapies, announced today the initiation of its first-in-human clinical study evaluating its novel Cardiac Leaflet Enhancer (CARLEN™) System in patients with functional (secondary) mitral…
ATLANTA, May 27, 2025 /PRNewswire/ — Nyra Medical, a leading innovator in structural heart therapies, today announced two key executive appointments that further solidify the company’s momentum as it advances its revolutionary Cardiac Leaflet Enhancer (CARLEN) System toward clinical and…
Financing co-led by Vensana Capital and a Large, Global Medical Device Company Use of Proceeds to Advance Development of a Novel Catheter-based Solution for Mitral Regurgitation ATLANTA, Nov. 23, 2022 /PRNewswire/ — Nyra Medical, Inc., a medical device company that is developing a novel transcatheter mitral valve repair technology, today announced the […]
